Biosimilar Inspection Modernization Act of 2025

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Introduced in Senate Dec 16, 2025 · 992 words Open full page ↗

119TH CONGRESS

1ST SESSION

S. 3510

To improve the inspections of drug establishments engaged in the manufac-

ture, preparation, propagation, or processing of biosimilar biological prod-

ucts conducted by the Food and Drug Administration, and for other

purposes.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 2%, measured from US's completed sessions
Momentum -7 17/100 from the pace of recorded action
Time since last action -22 305 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.